PTC 240624

Your search result can be sorted in ascending/descending order by clicking on the column headings, with the exception of Review Status/Past Decision(s).
* Please click on the DIN/PIN hyperlink to look up for more details of any group coverage(s) which may apply to that particular drug product.

Products Found: 6

MFR

Review Status/
Past Decision(s)

ALIROCUMAB
PRALUENT
150 MG / ML
INJ 
256.2100
N/A
ML
NO

SPECIAL AUTHORIZATION

ALIROCUMAB
PRALUENT
150 MG / SYR
INJ 
256.2100
N/A
SYR
NO

SPECIAL AUTHORIZATION

ALIROCUMAB
PRALUENT
75 MG / ML
INJ 
256.2100
N/A
ML
NO

SPECIAL AUTHORIZATION

ALIROCUMAB
PRALUENT
75 MG / SYR
INJ 
256.2100
N/A
SYR
NO

SPECIAL AUTHORIZATION

EVOLOCUMAB
REPATHA AUTOINJECTOR
140 MG / SYR
INJ  NDL
251.9100
N/A
SYR
NO

SPECIAL AUTHORIZATION

EVOLOCUMAB
REPATHA
420 MG
INJ  CTG
545.7998
N/A
CTG
NO

SPECIAL AUTHORIZATION


To return to the printable Drug Benefit List and related publications, click here.

Last Updated: null

NOTICE:
The DBL, DBS and related publications require knowledgeable interpretation and are intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.

Electronic versions of all DBL and DBS related publications are unofficial versions and are provided for convenience and private use only. Official paper versions can be obtained from Alberta Blue Cross who publishes them on behalf of Alberta Health and Alberta Human Services.

Alberta Health reserves the right to make changes, without notice, to the List through the Interactive DBL(iDBL), and any such changes to the Interactive DBL(iDBL) are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates.